Shareholder rights law firm Johnson & Weaver, LLP has launched an
investigation into whether the board members of Durata Therapeutics,
Inc. (NASDAQ: DRTX) breached their fiduciary duties in connection with
the proposed sale of the Company to Actavis plc.
for DURATA SHAREHOLDER ALERT: Johnson & Weaver, LLP Launches an Investigation into the Proposed Sale of Durata Therapeutics, Inc. and Encourages Investors to Contact the Firm for Additional Information investment picks